Why DexCom Stock Rallied on Monday
Shares of (NASDAQ: DXCM) surged higher on Monday, gaining as much as 5.3%. As of 3:04 p.m. ET, the stock was still up 3.6%.
The catalyst that sent the medical device maker higher was bullish commentary by one Wall Street analyst.
Leerink analysts initiated coverage of DexCom with an outperform rating, while simultaneously assigning a $110 price target, according to The Fly. This would represent potential gains of 44% compared to the stock's closing price on Friday.
Source Fool.com
Dexcom Inc. Aktie
72,60 €
0,55 %
Die Community unterstützt Dexcom Inc. stark, mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 75 € für Dexcom Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 72.6 €.
